Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
parkinsons disease - search results
If you're not happy with the results, please do another search
Mouth and gut bacteria linked to brain changes in Parkinson’s disease
Scientists have found a link between bacteria in the mouth and gut and the progression of cognitive decline in Parkinson's disease.
How deep brain stimulation alleviates symptoms of Parkinson’s disease
A new study has explored how deep brain stimulation positively impacts patients with Parkinson’s disease.
Researchers identify the key metabolic drivers of Parkinson’s disease
Dr Sung Min Son and Prof David Rubinsztein (UK DRI at Cambridge) have identified a key enzyme driving forms of Parkinson’s disease, highlighting a promising new target for treatment.
Investigating environmental factors and their effects on Parkinson’s disease
Yesterday on World Parkinson's Day in the Journal of Parkinson's Disease, researchers revealed the potential environmental origins of Parkinson's disease.
Exploring HER-096: A novel approach to Parkinson’s Disease
Parkinson’s disease, a progressive neurodegenerative disorder, poses significant challenges for both patients and researchers. In a recent interview with Henri Huttunen from Herantis Pharma Plc, we delved into the intricacies of their potential novel disease-modifying therapy, HER-096.
AI to diagnose Parkinsons: A groundbreaking paradigm shift
In a groundbreaking collaboration, the Accelerated Capability Environment (ACE) has teamed up with the NHS's AI Skunkworks to harness AI to diagnose Parkinsons with unprecedented speed.
Progress in development of disease-modifying treatments in Parkinson’s Disease
Henri Huttunen, Chief Scientific Officer, Herantis Pharma Plc, charts progress in the development of disease-modifying treatments for Parkinson’s disease.
PKG (Personal Kinetigraph): Helping my Parkinson’s Disease patients
Parkinson’s Disease affects all activities of patient daily living but PKG can help.
Research reveals that anti-TNF drug reverses Dupuytren’s disease
A clinical trial at Oxford University has found that a drug used for rheumatoid arthritis can reverse Dupuytren’s disease, if taken early on.
JPND: Neurodegenerative disease research without boundaries
Jacqueline Hoogendam, JPND’s newly elected Vice-Chair and Executive Board member talks about JPND’s past and present strategies in its outreach campaign within and beyond Europe.
Death rate from Parkinson’s disease rises in US
The death rate from Parkinson’s disease has risen by 63% in the United States, according to a new study.
Novel digital biomarkers to aid in the diagnosis and tracking of symptoms in patients...
Dr Rutger Zietsma – CEO at Manus Neurodynamica Ltd – and PD Dr Angela Deutschländer share their vision on earlier diagnosis and objective symptom tracking with the NeuroMotor PenTM.
JPND: Enabling collaborative research in Alzheimer’s and Parkinson’s diseases
Professor of Neurology Thomas Gasser, JPND’s Scientific Advisory Board Chair and Director of the Department of Neurodegenerative Diseases, shares in an interview JPND’s innovative research and collaboration efforts in the universal race against Alzheimer’s and Parkinson’s diseases.
New treatments for neurodegenerative diseases
Professor Dame Pamela Shaw explains how the National Institute for Health Research (NIHR) supports experimental medicine and translational research in neurodegenerative diseases.
New research may benefit patients with early stage Parkinson’s disease
A new study published in the Movement Disorders journal, has paved the way for more research into identifying markers of progression for patients in the early stages of Parkinson’s disease
National Institutes of Health scientists adapt new brain disease test for Parkinson’s
National Institutes of Health scientists develop new brain disease test for the early diagnosis of Parkinson’s disease and dementia with Lewy bodies
The group, led by NIH’s National Institute of Allergy and Infectious Diseases (NIAID), tested 60 cerebral spinal fluid samples, including 12 from people with Parkinson’s disease, 17 from...
Parkinson’s disease: are conventional treatments working?
Ramón Cacabelos, President of EuroEspes Biomedical Research Centre looks at conventional pharmacological treatments for Parkinson’s disease
Restoring dopaminergic nerve cells in Parkinson’s disease
Dr Mehis Pilv, CEO and business development lead at Genecode, discusses the strides being made in Parkinson's disease research
Parkinson's disease is a slow but progressive neurodegenerative disorder. About 1% of people aged above 50 are affected worldwide. In Europe alone 1.2 million people suffer from Parkinson's disease, 127,000 of whom...
Brain disorders and the burden of diseases
Frédéric Destrebecq, Executive Director, and Vinciane Quoidbach, Public Health and Policy Project Manager at the European Brain Council, explain the socio-economic impact of interventions and the importance of early diagnosis with regard to brain disorders…
Depression, stroke, dementia, alcohol dependence, schizophrenia or anxiety will affect at least one in three...
Cambridge scientists find gut bacteria can remove toxic PFAS from the body
Cambridge scientists discover that certain gut bacteria can absorb and eliminate PFAS, toxic 'forever chemicals' linked to health risks.
